
Only 2% of patients with internal limiting membrane peeling developed an epiretinal membrane compared with 46% with no peeling.

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.

Only 2% of patients with internal limiting membrane peeling developed an epiretinal membrane compared with 46% with no peeling.

Fundus autofluorescence is a helpful tool for diagnosing central serous choroidopathy and planning treatment.

Immediate administration after radiation therapy is key.

This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.





















Quiescence, steroid-free quiescence achieved in VISUAL III trial

Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder



